Gelteq Limited Ordinary Shares

GELS | NASDAQ

Price Alert Chart Builder DCF Calculator

$0.57

+$0.01 (+1.44%)

At close: Sep 21, 2026, 4:00 PM ET

$0.55

-$0.02 (-3.51%)

Pre-market: Sep 22, 2026, 4:18 AM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

+1.44%

(1D)

Rating

Updated: Sep 11, 2026

26.5

Fundamentals Weak

Market Sentiment Neutral

Moat None

Full Analysis

Key Statistics

Market Data

Market Cap $5.24M

1D Range

0.56 0.60

52W Range

0.39 2.01

Valuation (TTM)

PE -

PB 0.50

EV/EBITDA -7.96

Valuation (NTM)

Forward PE N/A

Forward PEG -0.02

Price Target N/A

Cash Flow

FCF Yield -16.0%

SBC Adj. FCF Yield -16.0%

SBC Impact N/A

Margins

Gross Margin 100.0%

Operating Margin -1986.0%

FCF Margin N/A

Growth (CAGR)

Revenue 3Y | 5Y 3.9% | 23.4%

Dil EPS 3Y | 5Y 150.0% | 31.1%

FCF 3Y | 5Y -70.2% | -52.1%

Returns

ROA -18.6%

ROE -24.9%

ROIC -18.3%

Financial Health

Net Debt

A$3.87M ($2.55M)

Current Ratio 0.09

Interest Coverage -3.93

Dividends

Div Yield N/A

Payout Ratio N/A

FCF Payout Ratio N/A

All Key Statistics

Loading financial charts...

Profile

Gelteq Limited, established in 2017 and based in Caulfield, Australia, specializes in creating and commercializing advanced gel-based delivery methods for both human and animal use. The company offers...

Sector Healthcare

Industry Drug Manufacturers - Specialty & Generic

Employees 18

IPO Date Oct 28, 2024

Website www.gelteq.com

Fiscal Year July - June

Full Company Profile

Latest News

No news articles available yet.